Pereiti į pagrindinį turinį
Home
language-selector-globe Lithuania | lt
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Lithuania
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Apie mus 
      • Novartis Lietuvoje 
      • Strategija 
      • Įvairovė ir įtrauktis 
      • Žmonės ir kultūra 
      • Produktai 
      • Susisiekite su mumis 
      Apie mus Apie mus
    • Pacientai ir slaugytojai 
      • Novartis įsipareigojimas pacientams ir slaugytojams 
      • Terapinės sritys 
      • Produktai 
      • Pranešti apie nepageidaujamą reiškinį 
        • Pranešti apie įtariamą nepageidaujamą reiškinį 
      • Parama pacientų organizacijoms 
      Gydytojas tikrina paciente su stratoskopu Pacientai ir slaugytojai
    • Sveikatos priežiūros specialistai 
      • Novartis interneto svetainė sveikatos priežiūros specialistams 
      • Produktai 
      • Novartis vystomų produktų asortimentas 
      • Pranešti apie nepageidaujamą reiškinį 
      • Bendradarbiavimas su sveikatos priežiūros specialistais 
      • Novartis klinikiniai tyrimai 
      Gydytojai kalbasi ligonineje Sveikatos priežiūros specialistai
    • Aplinkos apsauga, socialinė atsakomybė ir valdysena (ASV) 
      • Etika, rizikos valdymas ir atitiktis 
      • Prieinamumas 
      • Aplinkos tvarumas 
      • Pasaulinė sveikatos apsauga 
      • Etiškas elgesys 
        • Etikos kodeksas 
    • Naujienos 
      • Naujienų archyvas 
      • Susisiekite su mumis 
      A photo of people in a meeting hall Naujienos
    • Karjera 
      • Karjeros paieška 
      • Mūsų komandos 
      • Asmeninis augimas 
      • Jaunieji talentai 
      • Kaip mes dirbame 
      • Darbuotojų gerovė 
      • Įvairovė ir įtrauktis 
      • Apdovanojimai ir pripažinimas 
      Karjera Karjera
    • Koronavirusas 
      coronavirus-microscope-image Koronavirusas
    Vilniaus panorama Pagrindinis puslapis
  1. Pagrindinis puslapis
  2. Karjera
  3. Karjeros paieška
  • Sort by Sort ascending
  • Darbo pavadinimas
  • Svetainė
  • Vieta
  • Padalinys Sort descending
  • Veikla
  • Functional Area
  • Paskelbimo data
Darbo pavadinimas Svetainė Vieta Padalinys Sort descending Veikla Functional Area Paskelbimo data
Senior Principal Biostatistician Hyderabad (Office) India Development Innovative Medicines Research & Development Spa 03, 2024
Manager - Strategy and Operations Hyderabad (Office) India Development Innovative Medicines Research & Development Spa 03, 2024
Associate Manager- RIM Hyderabad (Office) India Development Innovative Medicines Research & Development Spa 08, 2024
Senior Clinical Research Associate Field Non-Sales (USA) USA Development Innovative Medicines Research & Development Spa 08, 2024
Postdoc Patient-Centered Outcomes Basel (City) Switzerland Development Innovative Medicines Others Spa 09, 2024
Clinical Ops Manager (Feasibility) East Hanover USA Development Innovative Medicines Research & Development Spa 15, 2024
SSU Manager INSURGENTES Mexico Development Innovative Medicines Research & Development Spa 15, 2024
Senior Expert Technical Development - Cell Therapy Process Development Project Lead East Hanover USA Development Innovative Medicines Research & Development Spa 15, 2024
Director Science & Technology Basel (City) Switzerland Development Innovative Medicines Research & Development Spa 16, 2024
SSO Study Start-Up Manager London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Spa 16, 2024
Director, Development Unit Management Basel (City) Switzerland Development Innovative Medicines Research & Development Spa 16, 2024
GCP Inspection Project Manager London (The Westworks) United Kingdom Development Innovative Medicines Quality Spa 16, 2024
Senior Expert Science & Technology, Analytical Development East Hanover USA Development Innovative Medicines Research & Development Spa 16, 2024
RA Operational Excellence Junior Associate – MEA Dubai Utd.Arab Emir. Development Innovative Medicines Research & Development Spa 16, 2024
Country Patient Safety Head - France Paris Headquarter (Novartis Pharma S.A.S.) France Development Innovative Medicines Research & Development Spa 17, 2024
Senior Expert Technical Development- Drug Product Project Lead East Hanover USA Development Innovative Medicines Research & Development Spa 17, 2024
Vendor Alliance Lead Associate Director East Hanover USA Development Innovative Medicines Research & Development Spa 17, 2024
Global Program Safety Lead - Immunology Basel (City) Switzerland Development Innovative Medicines Research & Development Spa 17, 2024
Global Program Safety Lead - Immunology London (The Westworks) United Kingdom Development Sandoz Research & Development Spa 17, 2024
Strategy Director, Clinical Development Basel (City) Switzerland Development Innovative Medicines Research & Development Spa 17, 2024
Senior Clinical Research Associate (Remote) Field Non-Sales (USA) USA Development Innovative Medicines Research & Development Spa 17, 2024
Senior Statistical Programmer Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Lie 18, 2024
Study Leader Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Rug 05, 2024
Head Regulatory Writing Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Spa 07, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Spa 09, 2024
Expert Science & Technology Changshu (Jiangsu Province) China Development Innovative Medicines Research & Development Rug 03, 2024
Regulatory Affairs Manager Beijing (Beijing) China Development Innovative Medicines Research & Development Rug 01, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Spa 09, 2024
Manager- Data Privacy Review and Remediation Telangana India Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compl. Spa 10, 2024
Associate Director - Risk & Assurance, EUROPE Prague Czech Republic Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Spa 11, 2024
Head DPDAI China Shanghai (Shanghai) China Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Spa 14, 2024
Associate Director, Data Privacy, Digital & AI East Hanover USA Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compl. Rug 04, 2024
Associate Director ERC Risk&Operations, Corporate Functions Selangor Malaysia Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compl. Rugp 29, 2024
Sr Manager/Manager-Monitoring Shanghai (Shanghai) China Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Lie 18, 2024
Ethics, Risk & Compliance Manager Selangor Malaysia Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Rugp 22, 2024
Manager- Data Privacy Review and Remediation Selangor Malaysia Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compl. Spa 14, 2024
Risk & Assurance Manager Mumbai (Head Office) India Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Spa 16, 2024
Country ERC Head, India Mumbai (Office) India Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Spa 16, 2024
Senior Financial Analyst- BPA Hyderabad (Office) India Finance CTS Audit & Finance Spa 10, 2024
Digital Finance, Data & Tools Analyst Barcelona Gran Vía Spain Finance CTS Audit & Finance Spa 11, 2024
Financial Reporting & Accounting Specialist Baarle Nassau Netherlands Finance Sandoz Audit & Finance Spa 11, 2024
Global FC&C Process Expert (Senior Manager) PIN-PCA Prague Czech Republic Finance CTS Audit & Finance Spa 03, 2024
P2P Service Delivery (SD) Lead NGSC INSURGENTES Mexico Finance CTS Audit & Finance Spa 07, 2024
Finance Control and Compliance US Manager INSURGENTES Mexico Finance CTS Audit & Finance Spa 08, 2024
General Accounting Manager INSURGENTES Mexico Finance CTS Audit & Finance Spa 09, 2024
Procure to Pay Business Partner Management INSURGENTES Mexico Finance CTS Audit & Finance Spa 16, 2024
Order to Cash RLT Sr. Specialist INSURGENTES Mexico Finance CTS Audit & Finance Spa 16, 2024
Alternant CONTRÔLE DE GESTION - BPA Paris Headquarter (Novartis Pharma S.A.S.) France Finance Innovative Medicines Others Gegužė 17, 2024
Procure to Pay Senior Specialist MR11 INSURGENTES Mexico Finance CTS Audit & Finance Lie 23, 2024
Order to Cash Radioligand Therapy Sr. Specialist INSURGENTES Mexico Finance CTS Audit & Finance Rugp 06, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 42
  • › Next page

Novartis Lietuvoje

Naršyti Novartis svetainėje
  • Pacientai ir slaugytojai
  • Sveikatos priežiūros specialistai
  • Kompanijos etika
  • Naujienos
  • Karjera
Naujienos
  • Naujienų archyvas
Musų portfelis
  • Novartis vystomų produktų asortimentas
  • Novartis produktai
Kitos Novartis svetainės
  • Pasaulinė svetainė
Footer Bottom
© 2024 Novartis AG
  • Privatumo politika
  • Naudojimo sąlygos
  • Slapukai
  • Slapukų nustatymai
  • Svetainės schema
  • Svetainės prieinamumas
Novartis svetainių katalogas
Ši svetainė skirta Lietuvos gyventojams